In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tight budgets must not hinder device tracking technologies uptake

This article was originally published in Clinica

Executive Summary

The US will soon move into the next phase of its plan to require all device manufacturers to have a system for identifying and tracking their devices. 30 September was the deadline for the CDRH’s test of Unique Device Identification (UDI) requirements. The FDA’s FY2010 planning document says that in less than three years – by 30 September 2013 – it plans to have implemented a UDI system.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts